glp-1 receptor agonist type 1 diabetes trial liraglutide Glucagon-like peptide-1 receptor: mechanisms and advances in therapy It's important to study the

Ann Pharmacother

But over the last few years a class of medicines originally developed to treat type 2 diabetes has shown dramatic effects on body weight

Weight loss drugs boost sales at retail pharmacies, but they may not help profits much

After that, if tolerated and under the supervision of your prescriber, the dose can be slowly increased up to 2.4 mg once a week

Abbott S, Chan F, Tahrani AA et al (2023) Weight management interventions for adults with idiopathic intracranial hypertension

The co-agonist reduced HbA1c by 1.36% and reduced body weight by 3.3%, while in participants receiving the active comparator liraglutide the respective differences were 0.96% and 1.7%